BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6063423)

  • 1. [Influence of three I.M.A.O. on pentetrazolic shock in the rabbit].
    Allain P; Eben-Moussi E; Van den Driessche J
    Therapie; 1967; 22(2):361-6. PubMed ID: 6063423
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of some monoamine oxidase inhibitors on the refractory period of isolated rabbit auricles.
    Bose D
    Indian J Physiol Pharmacol; 1968 Jan; 12(1):63-4. PubMed ID: 5673672
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of various monoamine oxidase inhibitors on the structure of the sleep-wakefulness cycle of the cat].
    Oniani TN; Akhvlediani GR
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):332-7. PubMed ID: 3582693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide].
    Lapin IP; Samsonova ML
    Farmakol Toksikol; 1969; 32(5):526-30. PubMed ID: 5364661
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of some monoamine oxidase inhibitors on the sleep-wakefulness cycle of the cat.
    Oniani TN; Akhvlediani GR
    Neurosci Behav Physiol; 1988; 18(4):301-6. PubMed ID: 3200413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorescence and electron microscopic study on central monoamine nerve cells.
    Fuxe K; Hökfelt T; Nilsson O; Reinius S
    Anat Rec; 1966 May; 155(1):33-40. PubMed ID: 5961819
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats].
    Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB
    Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732
    [No Abstract]   [Full Text] [Related]  

  • 9. A further contribution to the study of catecholamine flow in amphibian nerves.
    Rodríguez Echandía EL; Donoso AO; Pedroza E
    Acta Physiol Lat Am; 1972; 22(3):161-5. PubMed ID: 4120175
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between catecholamines and tricyclic and monoamine oxidase inhibitor antidepressive agents in man.
    Barar FS; Boakes AJ; Benedikter LB; Laurence DR; Prichard BN; Teoh PC
    Br J Pharmacol; 1971 Oct; 43(2):472P-473P. PubMed ID: 5158242
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine oxidase inhibitors and sleep.
    Akindele MO; Evans J; Oswald I
    Electroencephalogr Clin Neurophysiol; 1970 Apr; 28(4):429. PubMed ID: 4191235
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of adrenolytic agents (alpha and beta blockaders), of a monoamine oxidase inhibitor and of an SH donor (Agr 307) on the serum glycuronidase increase induced by adrenaline infusion].
    Laborit H; Baron C; Laurent J
    Agressologie; 1974; 15(2):111-5. PubMed ID: 4447136
    [No Abstract]   [Full Text] [Related]  

  • 13. Dextromethorphan-monoamine oxidase inhibitor interaction in rabbits.
    Sinclair JG
    J Pharm Pharmacol; 1973 Oct; 25(10):803-8. PubMed ID: 4149741
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal and brain catecholamine responses to acute and chronic morphine administration to rats, after inhibition of tyrosine hydroxylase and monoamine oxidase.
    Guaza C; Torrellas A; Borrell J; Borrell S
    Arch Farmacol Toxicol; 1983 Aug; 9(2):131-40. PubMed ID: 6140899
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of insulin hypoglycaemia by M.A.O.I. antidepressant drugs.
    Cooper AJ; Ashcroft G
    Lancet; 1966 Feb; 1(7434):407-9. PubMed ID: 4159787
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged fibrinolytic prophylactic treatment with nicotinic acid derivatives and MAO-inhibitors.
    De Nicola P
    Thromb Diath Haemorrh Suppl; 1966; 20():289-95. PubMed ID: 5298378
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of monoamine oxidase inhibitors on conjugation.
    Hargreaves T
    Experientia; 1968 Feb; 24(2):157-8. PubMed ID: 5643811
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiac catecholamines after ligation of the coronary artery. Influence of a monoaminoxidase inhibitor (nialamide) on the infarct].
    SERRANO PA; VILLANUEVA SA; LERDO DE TEJADAHAY A; CASTANEDA Y; CHAVEZ LARA B; BISTENI A
    Arch Inst Cardiol Mex; 1961; 31():197-204. PubMed ID: 13910885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of experimental hemorrhagic shock designated "irreversible". Role of SH groups and restoration of intraparticular reserves of catecholamines. I. Comprehensive view].
    Laborit H; Baron C; Weber B
    Agressologie; 1969; 10(3):189-98. PubMed ID: 5361352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.